Kenny S. Frazier
Profile
Kenny S.
Frazier held the position of Senior Director-Clinical Operations at Lexicon Pharmaceuticals, Inc. and the position of VP-Clinical Development & Regulatory Affairs at Opexa Therapeutics, Inc. He obtained an undergraduate degree from Texas Tech University.
Former positions of Kenny S. Frazier
| Companies | Position | End |
|---|---|---|
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Chief Tech/Sci/R&D Officer | - |
| LEXICON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2012-09-12 |
Training of Kenny S. Frazier
| Texas Tech University | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
- Stock Market
- Insiders
- Kenny S. Frazier
